Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 2385 results found since Jan 2013.
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine
ConclusionMost primary care physicians welcome updated ACIP RZV recommendations for immunocompromised adults. Knowledge gaps, communication issues, and financial barriers need to be addressed to optimize vaccination delivery.
Source: Journal of General Internal Medicine - July 6, 2022 Category: Internal Medicine Source Type: research
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
The objective of this study was to critically review the cost-effectiveness (CE) of the recombinant zoster vaccine (RZV) against herpes zoster (HZ). A literature review was conducted in PubMed, Embase, and Cochrane between January 1, 2017, and February 28, 2022, and on select public healthcare agency websites to identify and collect data from CE studies comparing RZV to zoster vaccine live (ZVL) or to no vaccination. Study characteristics, inputs, and outputs were collected. The overall CE of RZV was assessed. RZV vaccination against HZ is cost-effective in 15 out of 18 studies included in the present review. Varying incre...
Source: Herpes - March 14, 2023 Category: Infectious Diseases Authors: Nikolaos Giannelos Cheryl Ng Desmond Curran Source Type: research
Relationship of Income and Health Care Coverage to Receipt of Recommended Clinical Preventive Services by Adults - United States, 2011-2012.
This report summarizes the findings for six services covered by the Affordable Care Act. Among the six services examined, three were received by less than half of the persons for whom they were recommended (testing for human immunodeficiency virus [HIV] and vaccination for influenza and zoster [shingles]). Having health insurance or a higher income was associated with higher rates of receiving these preventive services, affirming findings of previous studies. Securing health insurance coverage might be an important way to increase receipt of clinical preventive services, but insurance coverage is not all that is needed to ...
Source: MMWR Morb Mortal Wkl... - August 8, 2014 Category: Epidemiology Authors: Fox JB, Shaw FE, Office of Health System Collaboration, Office of the Associate Director for Policy, CDC Tags: MMWR Morb Mortal Wkly Rep Source Type: research
A Review of Racial and Ethnic Disparities in Immunizations for Elderly Adults
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211014071. doi: 10.1177/21501327211014071.ABSTRACTVaccine preventable diseases are responsible for a substantial degree of morbidity in the United States as over 18 million annual cases of vaccine preventable disease occur in the U.S. annually. The morbidity due to vaccine preventable disease is disproportionately borne by adults as over 99% of the deaths due to vaccine preventable diseases occur within adults, and national data indicates that there racial disparities in the receipt of vaccines intended for elderly adults. A literature review was conducted by using the ...
Source: Primary Care - May 25, 2021 Category: Primary Care Authors: Oluchi Elekwachi La'Marcus T Wingate Veronica Clarke Tasker Lorraine Aboagye Tadesse Dubale Dagmawit Betru Razan Algatan Source Type: research
Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease
CONCLUSIONS: There is room for improvement of vaccination recommendations by PCPs. Promoting continuing education and use of clinical tools may help support PCP immunization practices for patients with IBD.PMID:35779060 | DOI:10.1093/ibd/izac129
Source: Herpes - July 2, 2022 Category: Infectious Diseases Authors: Fang Xu Neal deJong Michael D Kappelman Kurt J Greenlund Susan A Carlson Source Type: research
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | PMC:PMC9340059 | DOI:10.1016/j.ejim.2022.07.022
Source: European Journal of Internal Medicine - August 5, 2022 Category: Internal Medicine Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research
Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece
CONCLUSIONS: Vaccination rates of patients with T2D show an increasing trend, especially for influenza and S. pneumoniae, although the one for S. pneumoniae was low. Older people seem more prone to vaccination, the one for herpes zoster was low with infected patients remaining unvaccinated while significantly low coverage was observed for other VPDs. The findings are important to improve effectiveness of preventative services.PMID:35979460 | PMC:PMC9376377 | DOI:10.3389/fpubh.2022.921243
Source: Herpes - August 18, 2022 Category: Infectious Diseases Authors: Georgios Galanos Helen Dimitriou Angelos Pappas Chrysoula Perdikogianni Emmanouil K Symvoulakis Emmanouil Galanakis Christos Lionis Source Type: research
Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of varicella-zoster virus immunoglobulin G antibodies in fingerstick blood
J Immunol Methods. 2023 Jan 20:113429. doi: 10.1016/j.jim.2023.113429. Online ahead of print.ABSTRACTVaricella zoster virus (VZV) causes childhood chickenpox, becomes latent in sensory ganglia and reactivates years later to cause shingles (Zoster) and postherpetic neuralgia in the elderly and immunosuppressed individuals. Serologic IgG tests can be used to determine if a person has antibodies to VZV from past varicella infection or had received varicella or zoster (shingles) vaccination. Commercial enzyme-linked immunosorbent assays (ELISAs) are currently used for the detection of VZV IgG antibodies in patient serum sample...
Source: Journal of Immunological Methods - January 23, 2023 Category: Allergy & Immunology Authors: Nicholas Vafai Kevin Self Bret Sheffield Sally Hojvat Aubrey Kusi-Appiah Patrick Vaughan Elliot Cowan Abbas Vafai Source Type: research
